Keyphrases
Type 2 Diabetic Patients
100%
Liraglutide
100%
Renal Impairment
100%
Risk Factors
100%
Treatment Effect
100%
Pleiotropic Effects
100%
Hemoglobin A1c (HbA1c)
50%
P Factor
33%
Good Responders
33%
Low-density Lipoprotein Cholesterol (LDL-C)
33%
Albumin-to-creatinine Ratio
33%
Estimated Glomerular Filtration Rate
33%
Systolic Blood Pressure
33%
Low Responder
33%
Renal Risk
16%
Type 2 Diabetes Mellitus (T2DM)
16%
HbA1c Reduction
16%
Treatment Response
16%
Body Weight Reduction
16%
Large Reduction
16%
Low Body Weight
16%
Renal Risk Factors
16%
Placebo Treatment
16%
Individual Response
16%
Cardiovascular Risk
16%
Medicine and Dentistry
Liraglutide
100%
Pleiotropy
100%
Patient with Type 2 Diabetes
100%
Moderate Renal Impairment
100%
Hemoglobin A1c
66%
Body Weight
66%
Systolic Blood Pressure
33%
Glomerular Filtration Rate
33%
Creatinine
33%
Low Density Lipoprotein Cholesterol
33%
Maturity Onset Diabetes of the Young
16%
Cardiovascular System
16%
Treatment Response
16%
Placebo
16%
Response Factor
16%
Pharmacology, Toxicology and Pharmaceutical Science
Liraglutide
100%
Moderate Renal Impairment
100%
Non Insulin Dependent Diabetes Mellitus
100%
Hemoglobin A1c
66%
Low Density Lipoprotein Cholesterol
33%
Creatinine
33%
Placebo
16%
Biochemistry, Genetics and Molecular Biology
Pleiotropy
100%
Liraglutide
100%
Body Weight
66%
Creatinine
33%
Low-Density Lipoprotein
33%
Glomerulus Filtration
33%
Systolic Blood Pressure
33%
Response Factor
16%
Immunology and Microbiology
Pleiotropy
100%
Body Weight
100%
Albumin
50%
Low-Density Lipoprotein
50%
Glomerulus Filtration
50%
Systolic Blood Pressure
50%
Veterinary Science and Veterinary Medicine
Liraglutide
100%
Creatinine
33%
Blood Pressure
16%
Hypotension
16%